These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 796907)

  • 21. Renal effects of uricosuric agents in the chimpanzee.
    Fanelli GM; Bohn DL; Reilly SS
    J Pharmacol Exp Ther; 1971 Jun; 177(3):591-9. PubMed ID: 5568813
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of pharmaca-in vivo and in vitro-on a new enzymatic colorimetric uric acid test (author's transl)].
    Mathies H; Staehler F; Wittner H; Vollmar J
    Med Klin; 1974 Apr; 69(14):607-12. PubMed ID: 4838937
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic hazard.
    Br Med J; 1971 Aug; 3(5773):493. PubMed ID: 5570645
    [No Abstract]   [Full Text] [Related]  

  • 24. The renal mechanisms for the excretion of m-hydroxybenzoic acid in Cebus monkeys: relationship to urate transport.
    May DG; Weiner IM
    J Pharmacol Exp Ther; 1971 Feb; 176(2):407-17. PubMed ID: 4998692
    [No Abstract]   [Full Text] [Related]  

  • 25. Uricosurics and xanthine oxidase inhibitors: a single-dose assay.
    McMahon FG
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):414-7. PubMed ID: 4987349
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of uricosuric action of AA-193 in DBA/2N mice.
    Dan T; Tanaka H; Koga H
    J Pharmacol Exp Ther; 1990 May; 253(2):437-43. PubMed ID: 2338641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
    Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kidney repercussions of bile duct contrast media administration].
    Billis A; Dimopoulos C; Giamarellou H; Zoubouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daikos G
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):447-50. PubMed ID: 4804417
    [No Abstract]   [Full Text] [Related]  

  • 29. [What is certain in gout therapy?].
    Gottesbüren H; Strohmeyer G
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract]   [Full Text] [Related]  

  • 30. [Uricosuric action of endoiodine].
    Pena Yáñez A; Salmerón Escobar J; Raya Muñóz J; Bermudez Garcia J
    Rev Clin Esp; 1979 Feb; 152(4):271-3. PubMed ID: 451301
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hyperuricemia due to diuretics in hypertensive patients. Curative treatment with benziodarone].
    Lagrue G; Menard J; Safar M; Schlotterer P; Milliez P
    Presse Med (1893); 1971 Apr; 79(19):849-52. PubMed ID: 5576496
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of drugs on the renal handling of urate.
    Emmerson BT
    Prog Biochem Pharmacol; 1974; 9():142-52. PubMed ID: 4438376
    [No Abstract]   [Full Text] [Related]  

  • 33. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
    Simon JA
    Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
    [No Abstract]   [Full Text] [Related]  

  • 35. [The uricosuric effect of bilopaque (sodium tyropanoate). A contribution to the problem of nephro-toxicity of oral biliary contrast media].
    Burgener FA; Fischer HW
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Dec; 117(6):685-8. PubMed ID: 4346201
    [No Abstract]   [Full Text] [Related]  

  • 36. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic effects in man of tienilic acid, a new diuretic with uricosuric properties.
    Lemieux G; Gougoux A; Vinay P; Kiss A; Baverel G
    Nephron; 1978; 20(1):54-64. PubMed ID: 619301
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F; Saporta L; de Géry A; Jabre E
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the decrease of uric acid level in the plasma with benzbromarone].
    Zöllner N; Stern G; Gröbner W; Dofel W
    Klin Wochenschr; 1968 Dec; 46(24):1318-9. PubMed ID: 5714791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.